{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:55:09Z","timestamp":1788623709010,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier","isbn-type":[{"value":"9780443430862","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acr.2026.01.006","type":"book-chapter","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:14:38Z","timestamp":1770120878000},"page":"173-205","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic nanoparticles and targeted therapy"],"prefix":"10.1016","author":[{"given":"Vihaa Sriee","family":"Maambulikavil Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meethu","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Periasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"IAdvanced Drug Delivery Reviews"},{"key":"10.1016\/bs.acr.2026.01.006_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2019.03.056","article-title":"QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment","volume":"563","author":"Amasya","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.006_bib4","first-page":"2097","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand","year":"2008"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib5","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/D0MA00807A","article-title":"Nanomaterials: A review of synthesis methods, properties, recent progress, and challenges","volume":"2","author":"Baig","year":"2021","journal-title":"Materials Advances"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020318","article-title":"Nanosystems for improved targeted therapies in Melanoma","volume":"9","author":"Beiu","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib8","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.3390\/cancers3044024","article-title":"Nanoparticle delivery of natural products in the prevention and treatment of cancers: Current status and future prospects","volume":"3","author":"Bharali","year":"2011","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/bs.acr.2026.01.006_bib9","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevB.68.134433","article-title":"Magnetic enhancement of Co0.2Zn0.8Fe2O4 spinel oxide by mechanical milling","volume":"68","author":"Bhowmik","year":"2003","journal-title":"Physical Review B - Condensed Matter and Materials Physics"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cosmetics7020024","article-title":"New insights on unique features and role of nanostructured materials in cosmetics","volume":"7","author":"Bilal","year":"2020","journal-title":"Cosmetics"},{"issue":"7362","key":"10.1016\/bs.acr.2026.01.006_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10358","article-title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","volume":"477","author":"Breitbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.acr.2026.01.006_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00044-3","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"54","author":"Brigger","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.acr.2026.01.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00044-3","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"54","author":"Brigger","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425240903579971","article-title":"Designer nanoparticles: Incorporating size, shape and triggered release into nanoscale drug carriers","volume":"7","author":"Caldorera-Moore","year":"2010","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.acr.2026.01.006_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nmat3792","article-title":"Strategies for advancing cancer nanomedicine","volume":"12","author":"Chauhan","year":"2013","journal-title":"Nature Materials"},{"key":"10.1016\/bs.acr.2026.01.006_bib17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S45429","article-title":"Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics","volume":"8","author":"Chen","year":"2013","journal-title":"International Journal of Nanomedicine"},{"issue":"7","key":"10.1016\/bs.acr.2026.01.006_bib18","doi-asserted-by":"crossref","DOI":"10.21276\/IERJ24449856325648","article-title":"A review of the sol-gel process and its application","volume":"10","author":"Subhayu Choudhury","year":"2024","journal-title":"International Education and Research Journal"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1515\/ntrev-2020-0117","article-title":"Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer","volume":"9","author":"Dasari","year":"2020","journal-title":"Nanotechnology Reviews"},{"key":"10.1016\/bs.acr.2026.01.006_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/895986","article-title":"Drug delivery nanoparticles in skin cancers","volume":"2014","author":"Dianzani","year":"2014","journal-title":"BioMed Research International"},{"issue":"7639","key":"10.1016\/bs.acr.2026.01.006_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","article-title":"The big picture on nanomedicine: The state of investigational and approved nanomedicine products","volume":"9","author":"Etheridge","year":"2013","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"key":"10.1016\/bs.acr.2026.01.006_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jmr.2015.08.009","article-title":"Gd(III) complexes for electron-electron dipolar spectroscopy: Effects of deuteration, pH and zero field splitting","volume":"259","author":"Garbuio","year":"2015","journal-title":"Journal of Magnetic Resonance"},{"key":"10.1016\/bs.acr.2026.01.006_bib24","article-title":"Nanoparticles for cancer therapy: Current progress and challenges","volume":"16","author":"Gavas","year":"2021"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nano11040964","article-title":"Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells","volume":"11","author":"Gomes","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/bs.acr.2026.01.006_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2022.1006628","article-title":"Localized topical drug delivery systems for skin cancer: Current approaches and future prospects","volume":"4","author":"Gupta","year":"2022","journal-title":"Frontiers in Nanotechnology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/2229-5178.120635","article-title":"Nanocarriers and nanoparticles for skin care and dermatological treatments","volume":"4","author":"Gupta","year":"2013","journal-title":"Indian Dermatology Online Journal"},{"key":"10.1016\/bs.acr.2026.01.006_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(01)00731-1","article-title":"Invited review skin, the final frontier","volume":"224","author":"Hadgraft","year":"2001","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urolonc.2007.03.015","article-title":"Nanoparticles for drug delivery in cancer treatment","volume":"26","author":"Haley","year":"2008","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib30","first-page":"874","article-title":"Insights into metabolic remodeling of the hypertrophic and failing myocardium","volume":"7","author":"Hill","year":"2014","journal-title":"Circulation: Heart Failure"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.006_bib31","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1021\/mp300254s","article-title":"Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection","volume":"9","author":"Hu","year":"2012","journal-title":"Molecular Pharmaceutics"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.006_bib32","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/nn301282m","article-title":"Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo","volume":"6","author":"Huang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/bs.acr.2026.01.006_bib33","first-page":"108","article-title":"Frontiers in the treatment of glioblastoma: Past, present and emerging","volume":"171","author":"Janjua","year":"2021"},{"issue":"47","key":"10.1016\/bs.acr.2026.01.006_bib34","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.1508516112","article-title":"Engineering opportunities in cancer immunotherapy","volume":"112","author":"Jeanbart","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-017-0833-y","article-title":"Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes","volume":"19","author":"Jose","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/bs.acr.2026.01.006_bib37","first-page":"19","article-title":"Chemotherapy resistance mechanisms in advanced skin cancer","volume":"11","author":"Kalal","year":"2017"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.754","article-title":"Characteristics of crude oil-degrading bacteria Gordonia iterans isolated from marine coastal in Taean sediment","volume":"8","author":"Kim","year":"2019","journal-title":"MicrobiologyOpen"},{"issue":"34","key":"10.1016\/bs.acr.2026.01.006_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14356\/kona.2017009","article-title":"Synthesis of nanoparticles by laser ablation: A review","volume":"2017","author":"Kim","year":"2017","journal-title":"KONA Powder and Particle Journal"},{"key":"10.1016\/bs.acr.2026.01.006_bib40","first-page":"87","article-title":"Nanoparticles for topical drug delivery: Potential for skin cancer treatment","volume":"153","author":"Krishnan","year":"2020"},{"key":"10.1016\/bs.acr.2026.01.006_bib41","series-title":"Energy, Environment, and Sustainability","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-981-10-7751-7_8","article-title":"Fabrication of nanostructures with bottom-up approach and their utility in diagnostics, therapeutics, and others","author":"Kumar","year":"2018"},{"key":"10.1016\/bs.acr.2026.01.006_bib42","first-page":"107","article-title":"Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy","volume":"80","author":"Levenson","year":"2022"},{"issue":"24","key":"10.1016\/bs.acr.2026.01.006_bib43","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/1078-0432.CCR-10-0978","article-title":"Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine","volume":"16","author":"Libutti","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.acr.2026.01.006_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/IJN.S150086","article-title":"Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery","volume":"13","author":"Lin","year":"2018","journal-title":"International Journal of Nanomedicine"},{"issue":"11","key":"10.1016\/bs.acr.2026.01.006_bib45","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.biomaterials.2013.12.099","article-title":"The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/bs.acr.2026.01.006_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"Journal of nanobiotechnology"},{"issue":"4736","key":"10.1016\/bs.acr.2026.01.006_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/187493a0","article-title":"Stimulated Optical Radiation in Ruby","volume":"187","author":"Maiman","year":"1960","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.006_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ma11050822","article-title":"A review of carbon nanomaterials\u2019 synthesis via the chemical vapor deposition (CVD) method","volume":"11","author":"Manawi","year":"2018","journal-title":"Materials"},{"key":"10.1016\/bs.acr.2026.01.006_bib49","first-page":"569","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016"},{"issue":"7","key":"10.1016\/bs.acr.2026.01.006_bib50","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2967\/jnumed.106.039131","article-title":"Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes","volume":"48","author":"McDevitt","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.006_bib51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Molecular Pharmaceutics"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.006_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.04-2747rev","article-title":"Nanomedicine: Current status and future prospects","volume":"19","author":"Moghimi","year":"2005","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.acr.2026.01.006_bib53","unstructured":"Neumann, O., Urban, A., Day, J., Lal, S., Nordlander, P., & Halas, N. J.\u00a0(n.d.). Supporting Information: Solar Vapor Generation Enabled by Nanoparticles."},{"key":"10.1016\/bs.acr.2026.01.006_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4535790","article-title":"Effect of lipid composition on in vitro release and skin deposition of curcumin encapsulated liposomes","volume":"2016","author":"Pamunuwa","year":"2016","journal-title":"Journal of Nanomaterials"},{"key":"10.1016\/bs.acr.2026.01.006_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomaterials Research"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/17425247.2013.776038","article-title":"Drug delivery to hair follicles","volume":"10","author":"Patzelt","year":"2013","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib57","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1039\/c2nr11606e","article-title":"Transdermal drug delivery: From micro to nano","volume":"4","author":"Pegoraro","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/bs.acr.2026.01.006_bib58","series-title":"Nanoscience in Dermatology","first-page":"177","article-title":"Challenges and opportunities of nanoparticle-based theranostics in skin cancer","author":"Pizzimenti","year":"2016"},{"issue":"12","key":"10.1016\/bs.acr.2026.01.006_bib59","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: An indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Experimental Dermatology"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/toxsci\/kfq267","article-title":"An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin","volume":"119","author":"Quiros","year":"2011","journal-title":"Toxicological Sciences"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.006_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1369-7021(06)71389-X","article-title":"Electrospun nanofibers: Solving global issues","volume":"9","author":"Ramakrishna","year":"2006","journal-title":"Materials Today"},{"key":"10.1016\/bs.acr.2026.01.006_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/S0190-9622(96)90137-1","article-title":"Current issues primary care in dermatology: Should it be? Whose role","volume":"35","author":"Ramsay","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/bs.acr.2026.01.006_bib63","first-page":"175","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019"},{"key":"10.1016\/bs.acr.2026.01.006_bib64","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2559.1998.00431.x","article-title":"Why classify basal cell carcinomas?","volume":"32","author":"Rippey","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/bs.acr.2026.01.006_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjorl.2025.101619","article-title":"Metastatic basal cell carcinoma: Case series and literature review","volume":"91","author":"Rodrigues","year":"2025","journal-title":"Brazilian Journal of Otorhinolaryngology"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: A clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/bs.acr.2026.01.006_bib67","article-title":"Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model","author":"Ryu","year":"2020","journal-title":"BioRxiv: The Preprint Server for Biology"},{"key":"10.1016\/bs.acr.2026.01.006_bib68","first-page":"11931","article-title":"How to face skin cancer with nanomaterials: A review","volume":"11","author":"Sabir","year":"2021"},{"issue":"22","key":"10.1016\/bs.acr.2026.01.006_bib69","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.acr.2026.01.006_bib70","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12094-012-0982-0","article-title":"Nanoemulsions and nanoparticles for non-melanoma skin cancer: Effects of lipid materials","volume":"15","author":"Severino","year":"2013","journal-title":"Clinical and Translational Oncology"},{"key":"10.1016\/bs.acr.2026.01.006_bib72","first-page":"1389","article-title":"Nanotechnology-based products for cancer immunotherapy","volume":"49","author":"Shams","year":"2022"},{"issue":"10","key":"10.1016\/bs.acr.2026.01.006_bib73","article-title":"Mechanical milling: A superior nanotechnological tool for fabrication of nanocrystalline and nanocomposite materials","volume":"11","author":"Sherif El-Eskandarany","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/bs.acr.2026.01.006_bib74","first-page":"20","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017"},{"key":"10.1016\/bs.acr.2026.01.006_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0408-4","article-title":"\u201cGreen\u201d synthesis of metals and their oxide nanoparticles: Applications for environmental remediation","volume":"16","author":"Singh","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.acr.2026.01.006_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/380371","article-title":"Treatment of facial basal cell carcinoma: A review","volume":"2011","author":"Smith","year":"2011","journal-title":"Journal of Skin Cancer"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.006_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics7030067","article-title":"The pros and cons of the use of laser ablation synthesis for the production of silver nano-antimicrobials","volume":"7","author":"Sportelli","year":"2018","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.006_bib78","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/nn500299p","article-title":"Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency","volume":"8","author":"Sykes","year":"2014","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/bs.acr.2026.01.006_bib79","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.sjbs.2020.08.029","article-title":"Anti-cancer activity of biosynthesized silver nanoparticles using Avicennia marina against A549 lung cancer cells through ROS\/mitochondrial damages","volume":"27","author":"Tian","year":"2020","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.12403","article-title":"Nanomedicines: Addressing the scientific and regulatory gap","volume":"1313","author":"Tinkle","year":"2014","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.006_bib82","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1755-148X.2009.00581.x","article-title":"Use of liposomes as drug delivery vehicles for treatment of melanoma","volume":"22","author":"Tran","year":"2009","journal-title":"Pigment Cell and Melanoma Research"},{"key":"10.1016\/bs.acr.2026.01.006_bib83","article-title":"Synthesis of nanoparticles using advanced techniques","volume":"8","author":"Vinukonda","year":"2025"},{"key":"10.1016\/bs.acr.2026.01.006_bib84","article-title":"Nanomedicine in action: An overview of cancer nanomedicine on the market and in clinical trials","volume":"2013","author":"Wang","year":"2013","journal-title":"Journal of Nanomaterials"},{"key":"10.1016\/bs.acr.2026.01.006_bib85","first-page":"138","article-title":"Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015"},{"key":"10.1016\/bs.acr.2026.01.006_bib86","first-page":"150","article-title":"Transdermal drug delivery: 30 + years of war and still fighting!","volume":"190","author":"Wiedersberg","year":"2014"},{"key":"10.1016\/bs.acr.2026.01.006_bib87","article-title":"Evaluating intrinsic and non-intrinsic cancer risk factors","volume":"9","author":"Wu","year":"2018"},{"key":"10.1016\/bs.acr.2026.01.006_bib88","author":"Yano","year":"2004","journal-title":"Antitumor activity of small interfering RNA\/cationic liposome complex in mouse models of cancer"},{"key":"10.1016\/bs.acr.2026.01.006_bib89","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2147\/IJN.S22411","article-title":"Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery","author":"Zhai","year":"2011","journal-title":"International Journal of Nanomedicine"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.006_bib90","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.tiv.2012.12.003","article-title":"Reduced cytotoxicity of silver ions to mammalian cells at high concentration due to the formation of silver chloride","volume":"27","author":"Zhang","year":"2013","journal-title":"Toxicology in Vitro"},{"key":"10.1016\/bs.acr.2026.01.006_bib91","first-page":"3","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019"},{"issue":"30","key":"10.1016\/bs.acr.2026.01.006_bib92","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1073\/pnas.1118425109","article-title":"Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation","volume":"109","author":"Zheng","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.006_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nature Reviews Immunology"}],"container-title":["Advances in Cancer Research","Innovative Nanotechnology: Transforming Skin Cancer Diagnosis and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:15:29Z","timestamp":1777493729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X26000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443430862"],"references-count":93,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2026.01.006","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}